
Kimberly Chong
Examiner (ID: 8669, Phone: (571)272-3111 , Office: P/1674 )
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1636, 1635, 1674 |
| Total Applications | 2007 |
| Issued Applications | 1153 |
| Pending Applications | 209 |
| Abandoned Applications | 674 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4853150
[patent_doc_number] => 20080318893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-25
[patent_title] => 'Blockade of Calcium Channels'
[patent_app_type] => utility
[patent_app_number] => 12/091653
[patent_app_country] => US
[patent_app_date] => 2006-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6324
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20080318893.pdf
[firstpage_image] =>[orig_patent_app_number] => 12091653
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/091653 | Blockade of Calcium Channels | Oct 25, 2006 | Abandoned |
Array
(
[id] => 6499896
[patent_doc_number] => 20100286230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'MODULATION OF TRPV EXPRESSION LEVELS'
[patent_app_type] => utility
[patent_app_number] => 12/090426
[patent_app_country] => US
[patent_app_date] => 2006-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10041
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20100286230.pdf
[firstpage_image] =>[orig_patent_app_number] => 12090426
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/090426 | Modulation of TRPV expression levels | Oct 19, 2006 | Issued |
Array
(
[id] => 4561345
[patent_doc_number] => 07838658
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-23
[patent_title] => 'siRNA silencing of filovirus gene expression'
[patent_app_type] => utility
[patent_app_number] => 11/584341
[patent_app_country] => US
[patent_app_date] => 2006-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 28496
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/838/07838658.pdf
[firstpage_image] =>[orig_patent_app_number] => 11584341
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/584341 | siRNA silencing of filovirus gene expression | Oct 19, 2006 | Issued |
Array
(
[id] => 5101202
[patent_doc_number] => 20070184464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'RNA probes'
[patent_app_type] => utility
[patent_app_number] => 11/548925
[patent_app_country] => US
[patent_app_date] => 2006-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2658
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20070184464.pdf
[firstpage_image] =>[orig_patent_app_number] => 11548925
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/548925 | RNA probes | Oct 11, 2006 | Abandoned |
Array
(
[id] => 211549
[patent_doc_number] => 07622455
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-11-24
[patent_title] => 'Methods for slowing familial ALS disease progression'
[patent_app_type] => utility
[patent_app_number] => 11/526134
[patent_app_country] => US
[patent_app_date] => 2006-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9561
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/622/07622455.pdf
[firstpage_image] =>[orig_patent_app_number] => 11526134
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/526134 | Methods for slowing familial ALS disease progression | Sep 20, 2006 | Issued |
Array
(
[id] => 5564652
[patent_doc_number] => 20090137505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same'
[patent_app_type] => utility
[patent_app_number] => 11/992261
[patent_app_country] => US
[patent_app_date] => 2006-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 5571
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20090137505.pdf
[firstpage_image] =>[orig_patent_app_number] => 11992261
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/992261 | Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same | Sep 19, 2006 | Abandoned |
Array
(
[id] => 5220281
[patent_doc_number] => 20070161592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-12
[patent_title] => 'Method of treating fear'
[patent_app_type] => utility
[patent_app_number] => 11/520591
[patent_app_country] => US
[patent_app_date] => 2006-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10522
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20070161592.pdf
[firstpage_image] =>[orig_patent_app_number] => 11520591
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/520591 | Method of treating fear | Sep 13, 2006 | Abandoned |
Array
(
[id] => 5929375
[patent_doc_number] => 20110039334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'CHIMERIC OLIGOMERIC COMPOUNDS FOR MODULATION OF SPLICING'
[patent_app_type] => utility
[patent_app_number] => 12/065250
[patent_app_country] => US
[patent_app_date] => 2006-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13423
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20110039334.pdf
[firstpage_image] =>[orig_patent_app_number] => 12065250
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/065250 | Chimeric oligomeric compounds for modulation of splicing | Aug 28, 2006 | Issued |
Array
(
[id] => 5368476
[patent_doc_number] => 20090306035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Compounds and Methods for modulating the Silencing of a Polynucleotide of Interest'
[patent_app_type] => utility
[patent_app_number] => 12/064932
[patent_app_country] => US
[patent_app_date] => 2006-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18094
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20090306035.pdf
[firstpage_image] =>[orig_patent_app_number] => 12064932
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/064932 | Compounds and Methods for modulating the Silencing of a Polynucleotide of Interest | Aug 24, 2006 | Abandoned |
Array
(
[id] => 5552866
[patent_doc_number] => 20090286852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-19
[patent_title] => 'RNA containing modified nucleosides and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/990646
[patent_app_country] => US
[patent_app_date] => 2006-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 28559
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20090286852.pdf
[firstpage_image] =>[orig_patent_app_number] => 11990646
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/990646 | RNA containing modified nucleosides and methods of use thereof | Aug 20, 2006 | Issued |
Array
(
[id] => 4652159
[patent_doc_number] => 20080039415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => 'RETROGRADE TRANSPORT OF SIRNA AND THERAPEUTIC USES TO TREAT NEUROLOGIC DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 11/464074
[patent_app_country] => US
[patent_app_date] => 2006-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9755
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20080039415.pdf
[firstpage_image] =>[orig_patent_app_number] => 11464074
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/464074 | RETROGRADE TRANSPORT OF SIRNA AND THERAPEUTIC USES TO TREAT NEUROLOGIC DISORDERS | Aug 10, 2006 | Abandoned |
Array
(
[id] => 5642720
[patent_doc_number] => 20060281175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-14
[patent_title] => 'RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)'
[patent_app_type] => utility
[patent_app_number] => 11/502876
[patent_app_country] => US
[patent_app_date] => 2006-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 82
[patent_figures_cnt] => 82
[patent_no_of_words] => 81725
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20060281175.pdf
[firstpage_image] =>[orig_patent_app_number] => 11502876
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/502876 | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) | Aug 10, 2006 | Abandoned |
Array
(
[id] => 5000351
[patent_doc_number] => 20070042985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-22
[patent_title] => 'Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical field'
[patent_app_type] => utility
[patent_app_number] => 11/501756
[patent_app_country] => US
[patent_app_date] => 2006-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12916
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20070042985.pdf
[firstpage_image] =>[orig_patent_app_number] => 11501756
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/501756 | Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical field | Aug 9, 2006 | Abandoned |
Array
(
[id] => 5028916
[patent_doc_number] => 20070270363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'Modulation of telomere length by oligonucleotides having a G-core sequence'
[patent_app_type] => utility
[patent_app_number] => 11/502008
[patent_app_country] => US
[patent_app_date] => 2006-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6755
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20070270363.pdf
[firstpage_image] =>[orig_patent_app_number] => 11502008
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/502008 | Modulation of telomere length by oligonucleotides having a G-core sequence | Aug 8, 2006 | Abandoned |
Array
(
[id] => 4971225
[patent_doc_number] => 20070111227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-17
[patent_title] => 'Small regulatory RNAs and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/495951
[patent_app_country] => US
[patent_app_date] => 2006-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 29264
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20070111227.pdf
[firstpage_image] =>[orig_patent_app_number] => 11495951
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/495951 | Small regulatory RNAs and methods of use | Jul 27, 2006 | Abandoned |
Array
(
[id] => 5205619
[patent_doc_number] => 20070027101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'Methods for treating ocular neovascular diseases'
[patent_app_type] => utility
[patent_app_number] => 11/491818
[patent_app_country] => US
[patent_app_date] => 2006-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11767
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20070027101.pdf
[firstpage_image] =>[orig_patent_app_number] => 11491818
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/491818 | Methods for treating ocular neovascular diseases | Jul 23, 2006 | Abandoned |
Array
(
[id] => 5205620
[patent_doc_number] => 20070027102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'Methods and compositions for treating macular degeneration'
[patent_app_type] => utility
[patent_app_number] => 11/491819
[patent_app_country] => US
[patent_app_date] => 2006-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10556
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20070027102.pdf
[firstpage_image] =>[orig_patent_app_number] => 11491819
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/491819 | Methods and compositions for treating macular degeneration | Jul 23, 2006 | Abandoned |
Array
(
[id] => 5091696
[patent_doc_number] => 20070231335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => 'Compositions and methods for treating Gram positive bacterial infection in a mammalian subject'
[patent_app_type] => utility
[patent_app_number] => 11/490457
[patent_app_country] => US
[patent_app_date] => 2006-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 37300
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0231/20070231335.pdf
[firstpage_image] =>[orig_patent_app_number] => 11490457
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/490457 | Compositions and methods for treating Gram positive bacterial infection in a mammalian subject | Jul 18, 2006 | Abandoned |
Array
(
[id] => 4824903
[patent_doc_number] => 20080124315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-29
[patent_title] => 'Method of reducing CRF receptor mRNA'
[patent_app_type] => utility
[patent_app_number] => 11/488276
[patent_app_country] => US
[patent_app_date] => 2006-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8580
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20080124315.pdf
[firstpage_image] =>[orig_patent_app_number] => 11488276
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/488276 | Method of reducing CRF receptor mRNA | Jul 17, 2006 | Abandoned |
Array
(
[id] => 4944465
[patent_doc_number] => 20080081791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-03
[patent_title] => 'Methods of using combinations of siRNAs for treating a disease or a disorder, and for enhancing siRNA efficacy in RNAi'
[patent_app_type] => utility
[patent_app_number] => 11/481879
[patent_app_country] => US
[patent_app_date] => 2006-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 9198
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20080081791.pdf
[firstpage_image] =>[orig_patent_app_number] => 11481879
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/481879 | Methods of using combinations of siRNAs for treating a disease or a disorder, and for enhancing siRNA efficacy in RNAi | Jul 5, 2006 | Abandoned |